Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064360 · ClinicalTrials.gov registry record
Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 200
- Enrollment target
NCT03064360 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 200 participants.
The verdict
NCT03064360 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Usual care may not identify subtle clinical changes that precede a major adverse cardiovascular event (MACE). Therefore investigators will explore the effectiveness of using biomarkers, patient reported outcomes (PROs), and patient reported informatics (PRIs) as predictors to a MACE event.
Interventions
- OTHER Laboratory Biomarker Analysis
- BEHAVIORAL Questionnaires
- DEVICE Patient Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2020-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03064360
The ClinicalTrials.gov registry entry for NCT03064360 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03064360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03064360 about?
NCT03064360 is a clinical study titled "Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring". Usual care may not identify subtle clinical changes that precede a major adverse cardiovascular event (MACE). Therefore investigators will explore the effectiveness of using biomarkers, patient reported outcomes (PROs), and patient reported informatics (PRIs) as predictors to a MACE event.
What is the current status of trial NCT03064360?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-02-13. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03064360?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaires (BEHAVIORAL), Patient Activity (DEVICE).
Who is sponsoring clinical trial NCT03064360?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.